Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Unknown 4Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Observational Study 1Depression 1Bipolar Disorder 1Anxiety Disorders 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × drospirenone × Clear all
NCT04984070 2022-10-05

PCOS

Fudan University

Phase NA Unknown
100 enrolled

Anxiety Disorders, Bipolar Disorder, Depression, Polycystic Ovary Syndrome

NCT05135013 2021-11-26

The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study

NewGiza University

Unknown
200 enrolled

Observational Study

NCT03843736 2019-10-10

The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

Peking Union Medical College Hospital

Phase 3 Unknown
200 enrolled

Polycystic Ovary Syndrome

NCT01459445 2011-10-25

Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome

Iuliu Hatieganu University of Medicine and Pharmacy

Phase NA Unknown
26 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡